Hearing loss can be caused by a number of things, including consistent noise exposure, genetics, or natural aging. Fortunately, we have a variety of treatments options for those who suffer from hearing loss, but none thus far treat the underlying cause of hearing loss. However, now, pharmaceutical companies have begun clinical trials on new drugs and therapies which aim to prevent and cure hearing loss all together.
According to the New York Times, clinical trials of gene therapy has recently been initiated by Novartis. This company is aiming to restore damaged hair cells which is the cause of sensorineural hearing loss. The inner ear is home to over 15,000 hair cells which are responsible for transmitting sound signals to the auditory nerve. The auditory nerve then relays the sound information to the brain. When the hair cells are damaged, sounds can no longer be transmitted into the signals which are easily perceived by the brain. This loss of communication is what causes sensorineural hearing loss. The clinical trials sponsored by Novartis took a virus with the Atoh1 gene and injected it into the cochlea of a human in hopes to regrow these damaged hair cells. Although they did not find any significant change, this shows promise for the future.
Another promising drug experiment was done by Auris Medical. They reported that their experimental drug, which was injected through the ear drum into the middle ear, had improved hearing and speech discrimination for profoundly hearing impaired patients within 48 hours. Although, the drug did not improve hearing for those with mild or moderate hearing impairments.
Another approach in the medical field was to produce a drug that could reduce the oxidative damage to the ear. Sound Pharmaceuticals have began drug innovation which is intended to help prevent hearing loss. However, no significant results have been found in their experimental study.
Autifony Therapeutics has focused on creating a daily pill that aims to improve auditory interpretation. They believe that enhancing the communication between neurons is the best way to improve hearing. However, so far there hasn’t been any further testing conducted.
In the hopes of helping those who suffer from tinnitus (ringing in the ears), Auris has been running trials for AM-101, which is a derivate of the anesthetic ketamine. AM-101 aims to diminish the unnecessary signaling in the auditory nerve, which is perceived by the brain as tinnitus. Unfortunately, no significant effects were found in these studies. Although, there were reports from many patients stating that they believed their tinnitus had slightly softened.
Although these studies did not yield significant results it is wonderful to know that we are working towards a cure for hearing loss.
For the full story please click this link: New York Times Article
As the coronavirus impacts us all, please read how Davidson Hearing Aid Centres is working to create a safe environment for our staff and clients alike. Please note that our policies and office opening may be changing day-to-day as required. Please check back on our website to find the most up to date information.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and certain ITC are not wireless and will not function with this device.
The following Signia product families are compatible with this accessory.
The following Signia product families are compatible with this accessory.
The myHearing app works for all Andoid smartphones (Android 4.4 and newer) and iPhones (iOS version 8 and newer).
Full live remote tuning was tested and works best with the following devices:
• Google Nexus 6P (Android 7.1.1 or higher)
• Samsung Galaxy S8 – SM-G950F (Android 7.0 or higher)
• Samsung Galaxy S8 (USA) – SM-G950U (Android 7.0 or higher)
• Samsung Galaxy S7 – SM-G930F (Android 7.0 or higher)
• Samsung Galaxy S7 (USA) – SM-G930V (Android 7.0 or higher)
• Samsung Galaxy S7 Edge – SM-G935F (Android 7.0 or higher)
• Samsung Galaxy S6 – SM-920I (Android 6.0.1 or higher)
• Samsung Galaxy S6 Edge – SM-G925F (Android 7.0 or higher)
• Samsung Galaxy S5 – SM-G900F (Android 6.0.1 or higher)
The functionality of myControl App was tested and works best with the following Android devices:
• Google Nexus 6P (Android 7.1.1 or higher)
• Samsung Galaxy S8 – SM-G950F (Android 7.0 or higher)
• Samsung Galaxy S8 (USA) – SM-G950U (Android 7.0 or higher)
• Samsung Galaxy S7 – SM-G930F (Android 7.0 or higher)
• Samsung Galaxy S7 (USA) – SM-G930V (Android 7.0 or higher)
• Samsung Galaxy S7 Edge – SM-G935F (Android 7.0 or higher)
• Samsung Galaxy S6 – SM-920I (Android 6.0.1 or higher)
• Samsung Galaxy S6 Edge – SM-G925F (Android 7.0 or higher)
• Samsung Galaxy S5 – SM-G900F (Android 6.0.1 or higher)
This app can be used with any hearing aids as a guide for your first fit. The following Signia product families offer full conferencing with your professional as well as access to the full range of programming adjustments.
The following Signia product families offer a more limited range of fine tuning adjustments.
The following Signia product families are compatible with this accessory.
The following Signia product families are compatible with this accessory.
The following Widex product families are compatible with this accessory.
*Please note that the mini CIC’s are not wireless and will not function with these devices.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and certain ITC are not wireless and will not function with this device. Not compatible with the Audeo B-Direct.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and certain ITC are not wireless and will not function with this device. Not compatible with the Audeo B-Direct or the Audeo Q-10 products.
*Please note that the Audeo B-Direct, Virto B-Ti, or the Virto nano IIC are not compatible with this product.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and certain ITC are not wireless and will not function with this device. Not compatible with the Audeo B-Direct or the Audeo Q-10 products.
The following ReSound product families are compatible with this accessory.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and certain MIH and ITC are not wireless and will not function with this device.
The following ReSound product families are compatible with this accessory.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and many ITC are not wireless and will not function with this device.
The following ReSound product families are compatible with this accessory.
*Please note that it must be a wireless model. Many of the smaller custom products, including CIC and many ITC are not wireless and will not function with this device.
RC-DEX is designed for basic and easy wireless remote control of your hearing aids.